A Sniderman, K Williams, C Cobbaert - Current Atherosclerosis Reports, 2009 - Springer The high correlation between apolipoprotein B (apoB) and non–high-density
lipoprotein choles- terol (non–HDL-C) is the chief argument employed against
introducing apoB into clinical practice. How- ever, high correlation does ... Related articles - All 5 versions
ML Mestek - American Journal of Lifestyle Medicine, 2009 - ajl.sagepub.com Abstract: Dyslipidemia is a major modifiable cardiovascular disease (CVD) risk
factor. While pharmacolog- ical treatment has been a focal point of dyslipidemia
management for several years, increasing physical activity is a safe, cost- ... Related articles - All 2 versions